Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hans-Peter Hasler Insider Profile
4 Followers
Hans-Peter Hasler, Director at Shield Therapeutics, holds 5.50M shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Hans-Peter Hasler Bought 2,000,000p shares of Shield Therapeutics on Nov 27, 2023 for an estimated value of 122.00K.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-40.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Hans-Peter Hasler's holdings
Insider Roles
Director
Roles that Hans-Peter Hasler holds in companies
Most Profitable Insider Trade
The most profitable trade made by Hans-Peter Hasler
Hans-Peter Hasler's Trading History
List of latest transactions for each holding click on a transaction to see Hans-Peter Hasler's performance on stock
You May Also Like
Hans-Peter Hasler insider profile FAQ
What is the percentage of profitable transactions made by Hans-Peter Hasler?
The percentage of profitable transactions made by Hans-Peter Hasler is 0%.
What is the average return per transaction made by Hans-Peter Hasler?
The average return per transaction made by Hans-Peter Hasler is -40.80%.
What stocks does Hans-Peter Hasler hold?
Hans-Peter Hasler holds: GB:STX stocks.
What was Hans-Peter Hasler’s latest transaction?
Hans-Peter Hasler latest transaction was an Informative Buy of 122.00K.
What was Hans-Peter Hasler's most profitable transaction?
Hans-Peter Hasler’s most profitable transaction was an Informative Buy of GB:STX stock on December 13, 2022. The return on the trade was -5.10%.
What is Hans-Peter Hasler's role in Shield Therapeutics?
Hans-Peter Hasler's role in Shield Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.